One of these new generation compounds could prevent adipogenesis,insulin resistance, and obesity by blocking endogenous ligand-inducedactivation of PPARγ.In addition, these compounds may increase glucose disposal in peripheraltissues (see Figure 2) [76]. The gene discussed is PPARG; the disease is Insulin resistance.